Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ovarian Neoplasms

  Free Subscription


22.04.2024

2 Am J Surg Pathol
1 BMC Cancer
2 Br J Cancer
1 Cancer Res
2 Clin Cancer Res
2 Eur J Obstet Gynecol Reprod Biol
1 Gynecol Oncol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. FADARE O, Fard EV, Bhargava R, Desouki MM, et al
    The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.
    Am J Surg Pathol. 2024 Mar 21. doi: 10.1097/PAS.0000000000002201.
    PubMed         Abstract available

  2. RUIZ F, Tjendra Y, Millan N, Gomez-Fernandez C, et al
    Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Am J Surg Pathol. 2024 Feb 15. doi: 10.1097/PAS.0000000000002193.
    PubMed         Abstract available


    BMC Cancer

  3. DE OLIVEIRA FERREIRA C, Carneiro VCG, Araujo Mariz C
    Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System.
    BMC Cancer. 2024;24:499.
    PubMed         Abstract available


    Br J Cancer

  4. KMENT J, Newsted D, Young S, Vermeulen MC, et al
    Blockade of TGF-beta and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses.
    Br J Cancer. 2024 Apr 15. doi: 10.1038/s41416-024-02677.
    PubMed         Abstract available

  5. MONJE N, Dragomir MP, Sinn BV, Hoffmann I, et al
    AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
    Br J Cancer. 2024 Feb 9. doi: 10.1038/s41416-023-02550.
    PubMed         Abstract available


    Cancer Res

  6. WATERS JA, Robinson M, Lujano-Olazaba O, Lucht C, et al
    Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2613.
    PubMed         Abstract available


    Clin Cancer Res

  7. VENEZIANI AC, Sneha S, Oza AM
    Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile.
    Clin Cancer Res. 2024;30:1434-1437.
    PubMed         Abstract available

  8. GITTO SB, Whicker M, Davies G, Kumar S, et al
    A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression.
    Clin Cancer Res. 2024;30:1567-1581.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  9. GUZEL D, Terek C, Besler A, Serin G, et al
    PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:321-326.
    PubMed         Abstract available

  10. GUO L, Kang X, Su Y, Liu X, et al
    Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:107-113.
    PubMed         Abstract available


    Gynecol Oncol

  11. EHMANN S, Lam C, Zhou Q, Iasonos A, et al
    Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
    Gynecol Oncol. 2024;186:104-109.
    PubMed         Abstract available


    PLoS One

  12. LI N, Jin S, Wu J, Ji H, et al
    Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.
    PLoS One. 2024;19:e0299504.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.